PAYER POLICY CHANGES

C9300 Insurance Policy Changes

HCPCS C9300 is officially defined as "Injection, indigotindisulfonate sodium, 1 mg." HCPCS C9300 is referenced in 4 tracked payer policy changes from Michigan Medicaid - MDHHS, Blue Cross Blue Shield of Rhode Island, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9300 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch C9300

Get one email when a payer policy names C9300, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.